• Keros Therapeutics (NASDAQ:KROS) Price Target Cut to $43.00 by Analysts at Truist Financial

    来源: Buzz FX / 23 12月 2024 08:16:12   America/New_York


    Keros Therapeutics (NASDAQ:KROS) Price Target Cut to $43.00 by Analysts at Truist Financial Written by MarketBeat December 23, 2024 Share Link copied to clipboard. Keros Therapeutics ( NASDAQ:KROS - Get Free Report ) had its price objective
    Read more...
分享